CStone Pharmaceutical, an SIP-based innovative drug maker listed at Hong Kong Exchanges and Clearing Market in February, hosted a forum on Oct 11 when hundreds of medical experts, scholars and representatives of pharmaceutical enterprises and investment organizations discussed innovation and cooperation in the pharmaceutical sector under contemporary circumstances. At the event, CStone Pharmaceutical and Jiangsu Industrial Technology Research Institute (JITRI) jointly unveiled the nameplate for the JITRI-CStone Innovation Center. 

 

JITRI, based in Nanjing, capital of East China’s Jiangsu province, is dedicated to development of a wide range of technologies applied in various industrial sectors. The institute and its 50-plus branches can provide abundant technical and human resources for new drug development.

“Based on the center, JITRI and CStone will enhance exchange and cooperation to bring about win-win outcomes in medicine development,” said Jiang Ningjun, chairman and CEO of CStone Pharmaceutical.